Magnesium Sulfate for Pre-eclampsia and Eclampsia
Magnesium sulfate is the definitive anticonvulsant for preventing and treating seizures in pre-eclampsia and eclampsia, and should be administered to all women with pre-eclampsia who have proteinuria plus severe hypertension (≥160/110 mmHg), or any hypertension with neurological signs or symptoms. 1
Clear Indications for Magnesium Sulfate
Mandatory Use:
- Eclampsia (active seizures): Magnesium sulfate is superior to all other anticonvulsants for treating eclamptic seizures 2
- Pre-eclampsia with proteinuria AND severe hypertension (≥160/110 mmHg) 1
- Pre-eclampsia with neurological symptoms: headache, visual disturbances, hyperreflexia with clonus 1
- Severe pre-eclampsia with any severe features (thrombocytopenia, elevated liver enzymes, renal dysfunction, pulmonary edema) 3
Evidence of Efficacy:
Magnesium sulfate reduces eclampsia risk by more than half (RR 0.41,95% CI 0.29-0.58; NNT=100) compared to placebo, with a non-significant trend toward reduced maternal death (RR 0.54) 2. It is superior to phenytoin (RR 0.08) and nimodipine (RR 0.33) for seizure prevention 2, 4.
Standard Dosing Regimens
FDA-Approved Protocol 5:
Loading Dose:
- IV: 4-5 g diluted in 250 mL D5W or normal saline, infused over 15-20 minutes
- IM (alternative): 10 g total (5 g in each buttock using undiluted 50% solution)
Maintenance Dose:
- IV infusion: 1-2 g/hour continuous infusion
- IM (alternative): 4-5 g IM every 4 hours into alternate buttocks
Duration: Continue until 24 hours postpartum or 24 hours after last seizure 5
Important Dosing Notes:
- Recent evidence suggests 1 g/hour maintenance is as effective as 2 g/hour with significantly fewer maternal side effects (42% vs 71%, OR 1.69) 6
- In low-resource settings: 4 g IV loading dose OR 10 g IM loading dose, followed by 5 g IM every 4 hours 1
- Maximum daily dose: 30-40 g per 24 hours 5
- Severe renal insufficiency: Maximum 20 g per 48 hours with frequent serum monitoring 5
Critical Safety Monitoring
Clinical Monitoring (Essential):
- Patellar (knee-jerk) reflexes: Check before each IM dose or every 4 hours during IV infusion—loss of reflexes is the first sign of toxicity
- Respiratory rate: Must remain ≥12 breaths/minute
- Urine output: Must be ≥25-30 mL/hour (≥100 mL per 4 hours)
Therapeutic and Toxic Levels:
- Therapeutic range: 4-8 mEq/L (4.8-9.6 mg/dL) 5
- Optimal for seizure control: 6 mg/100 mL 5
- Loss of deep tendon reflexes: 10 mEq/L
- Respiratory depression: 12-15 mEq/L
- Cardiac arrest: >25 mEq/L
Toxicity Management:
Have calcium gluconate immediately available: 1 g (10 mL of 10% solution) IV over 3 minutes as antidote for magnesium toxicity 5
Common Side Effects and Drug Interactions
Expected Side Effects:
- Flushing: Occurs in ~24% of patients (vs 5% placebo; NNH=6) 2
- Warmth, sweating
- Mild hypotension
- Nausea
Critical Drug Interactions:
- Calcium channel blockers (nifedipine): Risk of severe hypotension and myocardial depression—use extreme caution when combining 7, 8
- Neuromuscular blocking agents: Magnesium potentiates effect
- CNS depressants: Additive sedation
Important Clinical Caveats
When NOT to Use Magnesium Sulfate:
- Myasthenia gravis (relative contraindication)
- Heart block or severe bradycardia
- Severe renal failure without dose adjustment
Duration Warnings:
Do not use magnesium sulfate continuously for >5-7 days during pregnancy—prolonged use can cause fetal skeletal abnormalities 5
Mild Pre-eclampsia Controversy:
While guidelines recommend magnesium sulfate primarily for severe features 1, observational data show that 25% of eclamptic women were normotensive and 25% were asymptomatic before seizure 9. However, current evidence-based practice reserves magnesium sulfate for pre-eclampsia with severe features rather than all mild pre-eclampsia 1, 3.
Blood Pressure Management:
Magnesium sulfate is NOT an antihypertensive agent—it prevents seizures but does not adequately control blood pressure. Severe hypertension (≥160/110 mmHg) requires concurrent treatment with labetalol IV, nifedipine PO, or hydralazine IV 1.
Practical Algorithm
For any woman with pre-eclampsia, administer magnesium sulfate if ANY of the following:
- Blood pressure ≥160/110 mmHg (with proteinuria)
- Severe headache unresponsive to analgesics
- Visual disturbances (scotomata, blurred vision)
- Hyperreflexia with sustained clonus
- Epigastric or right upper quadrant pain
- Platelet count <100,000/μL
- Elevated liver transaminases (>2× normal)
- Serum creatinine >1.1 mg/dL or doubling of baseline
- Pulmonary edema
- Active eclamptic seizure
Standard regimen: 4-5 g IV loading dose over 15-20 minutes, then 1 g/hour maintenance until 24 hours postpartum 1, 5, 6